Eterus Capital has partnered with Dr. Martin to expand its dental clinic network
Dr. Martin Dental Clinic, a leading network of dental clinics in Slovakia, has received a significant investment from Eterus Capital and Ethernum Capital to support its expansion across the country. The group aims to become Slovakia’s largest dental care provider through a "buy-and-build" strategy, combining new clinic openings with acquisitions.
Eterus Capital is a private equity fund founded in 2008, specializing in supporting small and medium-sized enterprises with proven business models and growth potential. The fund focuses on minority investments, ensuring management control remains with the original shareholders. Over the years, Eterus Capital has provided more than US$41 million (€40 million) in funding to over 20 companies. Its portfolio includes prominent brands such as Sygic, HOPIN, eyerim, Saneca Pharmaceuticals, Groupsolver and MTBIKER.
Dr. Martin is a leading private dental care group in Slovakia, with over a decade of experience offering comprehensive services such as implantology, prosthetics and other restorative and aesthetic dental treatments. The group currently operates four modern dental clinics and a pediatric clinic under the Dr. Martinko brand, employing approximately 130 professionals.
Oaklins’ team in Slovakia advised Eterus Capital on this transaction.
Talk to the deal team
Related deals
UKAT Group has acquired Bayberry Limited
UK Addiction Treatment (UKAT) Group, a leading UK provider of residential addiction, mental health and behavioral health treatment backed by Sullivan Street Partners, has acquired Bayberry Limited, a specialist mental health and wellbeing treatment provider. Joining UKAT enables Bayberry to preserve continuity of care for patients and referral partners, retain the strength of its clinical team and benefit from UKAT’s operational infrastructure, referral network and marketing channels. This partnership supports Bayberry’s next stage of development while preserving the qualities that differentiate its service offering.
Learn moreMedicija has acquired Saulės Šeimos Medicinos Centras
Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.
Learn moreQuimpharma has completed the divestiture of a product portfolio to Megalabs
Quimpharma has completed the divestiture of a product portfolio to Megalabs México.
Learn more